Physician profile
Ben Shofty
NPI 1699304022
$14,515.94
in general payments reported to CMS, 2019-2025
8 companies · $5,576 in 2025
The $5,576 reported for 2025 was more than what 81% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,165 · 2023: $3,958 · 2024: $1,817 · 2025: $5,576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,750 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,063 · Travel and Lodging: $2,538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,750.25 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,062.50 |
| Travel and Lodging | $2,538.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,888.47 | 2022-2025 | Infinity |
| Boston Scientific Corporation | $2,715.02 | 2022-2025 | Vercise, General - Dbs |
| Medtronic, INC. | $1,860.52 | 2022-2024 | Percept PC Brainsense, Sensight |
| Neuropace, INC. | $1,279.63 | 2022-2025 | |
| Monteris Medical Corporation | $1,181.41 | 2023 | Neuroblate |
| Dixi Medical USA Corp | $927.47 | 2023 | |
| Brainlab, INC. | $633.42 | 2023-2024 | Image Guided Surgical Device, Surgical Planning and Navigation Radiation Treatment Planning and Positioning |
| Depuy Synthes Sales INC. | $30.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Shofty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.